Search research articles
Contact Us
Filters
Showing results (1-10 of 204) with videos related to
Page
of 21
Sort By:
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
August 21, 2007
Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells
Saswati Hazra, Steven M Dubinett
Critical Reviews in Oncogenesis
|
June 10, 2016
Drug Development for Metastasis Prevention
Yari Fontebasso, Steven M Dubinett
Seminars in Respiratory and Critical Care Medicine
|
October 13, 2016
Lung Cancer: Evolving Concepts in Management
Douglas Arenberg, Steven M Dubinett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 5, 2013
Challenge and opportunity of targeted lung cancer chemoprevention
Steven M Dubinett, Avrum Spira
Translational Lung Cancer Research
|
February 11, 2020
Myeloid-derived suppressor cell-dependent inhibition of B cell responses in non-small cell lung cancer
Rui Li, Steven M Dubinett
Seminars in Oncology
|
June 5, 2004
COX-2 inhibition and lung cancer
Alan B Sandler, Steven M Dubinett
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 25, 2010
Poly(ADP-ribose) polymerase inhibitors
Edward B Garon, Steven M Dubinett
American Journal of Respiratory and Critical Care Medicine
|
March 29, 2018
Understanding the Hurdles in Lung Cancer Immunotherapy in the Context of Chronic Obstructive Pulmonary Disease
Ramin Salehi-Rad, Steven M Dubinett
American Journal of Respiratory and Critical Care Medicine
|
October 27, 2017
Impact of Chronic Obstructive Pulmonary Disease on Immune-based Treatment for Lung Cancer. Moving toward Disease Interception
Steven M Dubinett, Avrum E Spira
Journal of Thoracic Disease
|
April 10, 2019
Understanding the mechanisms of immune-evasion by lung cancer in the context of chronic inflammation in emphysema
Ramin Salehi-Rad, Steven M Dubinett
Page
of 21
Search research articles
Search
Showing results (1-10 of 204) with videos related to
Sort By:
Page
of 21
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
August 21, 2007
Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells
Saswati Hazra, Steven M Dubinett
Critical Reviews in Oncogenesis
|
June 10, 2016
Drug Development for Metastasis Prevention
Yari Fontebasso, Steven M Dubinett
Seminars in Respiratory and Critical Care Medicine
|
October 13, 2016
Lung Cancer: Evolving Concepts in Management
Douglas Arenberg, Steven M Dubinett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 5, 2013
Challenge and opportunity of targeted lung cancer chemoprevention
Steven M Dubinett, Avrum Spira
Translational Lung Cancer Research
|
February 11, 2020
Myeloid-derived suppressor cell-dependent inhibition of B cell responses in non-small cell lung cancer
Rui Li, Steven M Dubinett
Seminars in Oncology
|
June 5, 2004
COX-2 inhibition and lung cancer
Alan B Sandler, Steven M Dubinett
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 25, 2010
Poly(ADP-ribose) polymerase inhibitors
Edward B Garon, Steven M Dubinett
American Journal of Respiratory and Critical Care Medicine
|
March 29, 2018
Understanding the Hurdles in Lung Cancer Immunotherapy in the Context of Chronic Obstructive Pulmonary Disease
Ramin Salehi-Rad, Steven M Dubinett
American Journal of Respiratory and Critical Care Medicine
|
October 27, 2017
Impact of Chronic Obstructive Pulmonary Disease on Immune-based Treatment for Lung Cancer. Moving toward Disease Interception
Steven M Dubinett, Avrum E Spira
Journal of Thoracic Disease
|
April 10, 2019
Understanding the mechanisms of immune-evasion by lung cancer in the context of chronic inflammation in emphysema
Ramin Salehi-Rad, Steven M Dubinett
Page
of 21